Menstrual Blood Loss and Fibrin Degradation Products

Overview

Journal Br Med J

Specialty General Medicine

Date 1972 Jan 8

PMID 5007072

Citations 2

Authors

S K Cole

A R Clarkson

Affiliations

Soon will be listed here.

Abstract

As part of a large-scale study of menstrual blood loss in the community serum fibrin degradation products were measured soon after menstruation in 331 women. No significant correlation was found between the amount of blood lost and the serum level of fibrin degradation products. These findings conflict with reports suggesting that excessive intrauterine fibrinolysis, which may play a part in menorrhagia, is associated with raised serum F.D.P. concentrations.

Citing Articles

Endometrial haemostasis and menstruation.

Davies J, Kadir R Rev Endocr Metab Disord. 2012; 13(4):289-99.

PMID: 23180227 DOI: 10.1007/s11154-012-9226-4.

Clinical applications of fibrinolytic inhibition in gynaecology.

Bonnar J, Guillebaud J, Kasonde J, Sheppard B J Clin Pathol Suppl (R Coll Pathol). 1980; 14:55-9.

PMID: 7000848 PMC: 1347107.

References

MERSKEY C, Kleiner G, Johnson A . Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966; 28(1):1-18. View

RYBO G . Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss. Acta Obstet Gynecol Scand. 1966; 45(4):429-50. DOI: 10.3109/00016346609158462. View

Das P, Allan A, Woodfield D, Cash J . Fibrin degradation products in sera of normal subjects. Br Med J. 1967; 4(5581):718-20. PMC: 1748968. DOI: 10.1136/bmj.4.5581.718. View

Colman R, Braun W, BUSCH G, DAMMIN G, MERRILL J . Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med. 1969; 281(13):685-91. DOI: 10.1056/NEJM196909252811301. View

Basu H . Fibrin degradation products in sera of women with normal menstruation and menorrhagia. Br Med J. 1970; 1(5688):74-5. PMC: 1699183. DOI: 10.1136/bmj.1.5688.74. View

Das P . Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells. J Clin Pathol. 1970; 23(2):149-55. PMC: 474480. DOI: 10.1136/jcp.23.2.149. View

CHEYNE G, SHEPHERD M . Comparison of chemical and atomic absorption methods for estimating menstrual blood loss. J Med Lab Technol. 1970; 27(3):350-4. View

Clarkson A, Morton J, Cash J . Urinary fibrin-fibrinogen degradation poducts after renal homotransplantation. Lancet. 1970; 2(7685):1220-3. DOI: 10.1016/s0140-6736(70)92181-1. View

Nilsson L, RYBO G . Treatment of menorrhagia. Am J Obstet Gynecol. 1971; 110(5):713-20. DOI: 10.1016/0002-9378(71)90259-6. View

10.

Clarkson A, MACDONALD M, Petrie J, Cash J, Robson J . Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis. Br Med J. 1971; 3(5772):447-51. PMC: 1800376. DOI: 10.1136/bmj.3.5772.447. View

11.

Cole S, Billewicz W, Thomson A . Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw. 1971; 78(10):933-9. DOI: 10.1111/j.1471-0528.1971.tb00208.x. View

12.

Hoq M, Das P . Preparation of human cells for the assay of serum fibrinogen degradation products using haemagglutination inhibition. Scand J Haematol Suppl. 1971; 13:101-5. DOI: 10.1111/j.1600-0609.1971.tb01993.x. View

13.

HYTTEN F, CHEYNE G, KLOPPER A . IRON LOSS AT MENSTRUATION. J Obstet Gynaecol Br Commonw. 1964; 71:255-9. DOI: 10.1111/j.1471-0528.1964.tb04275.x. View

14.

Nilsson I, BJOERKMAN S . EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID (EPSILON-ACA) IN THE TREATMENT OF PROFUSE MENSTRUATION. Acta Med Scand. 1965; 177:445-57. View